BioSpace News Archive

NTx, a bioinformatics and biomanufacturing company advancing cell free, continuous flow manufacturing solutions for medical products and material sciences, announced that it has been awarded U.S. Patent 11,136,586 by the U.S. Patent and Trademark Office.

Alzheimer disease is the most common form of dementia which can impair the person’s daily functioning and is mainly characterized by loss of memory, loss of cognitive function and functional impairment.

There have been a number of measures taken to ensure sufficient supply of blood by blood banks.

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the European Commission (EC) has expanded the current indication for AYVAKYT® (avapritinib) to include monotherapy for the treatment of adult patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN) or mast cell leukemia (MCL), after at least one systemic therapy.

Muscle stimulators are making their way into the mainstream day by day and playing a crucial role in improve health conditions.

In the last few years, use of advanced medical devices over their conventional counterparts has highly increased, and surge in healthcare expenditure has played a pivotal role in the same.

The global acute repetitive seizures market is expected to grow at a CAGR of about 46.7% over the forecast period and to reach valuation US$ 4.3 billion by 2027.

The clinical communication and collaboration market is growing at a registered CAGR of 11.6% over the forecast period and to reach valuation US$ 3.6 billion by 2029.

As per Precedence Research, the immunotherapy drugs market size is expected to hit US$ 324.83 billion by 2030 from valued at US$ 176.94 billion in 2021, growing at a CAGR of 7.9%.

As per Precedence Research, the In Vitro Diagnostics (IVD) market size estimated at US$ 85.23 billion by 2027 and growing at a CAGR of 5% during the forecast period 2021 to 2027.